Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IVTCOVID 19 Trident

X
Drug Profile

IVTCOVID 19 Trident

Alternative Names: IVT-COVID19 Trident

Latest Information Update: 09 Dec 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Inventprise
  • Class COVID-19 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Research COVID 2019 infections

Most Recent Events

  • 29 Nov 2021 IVTCOVID 19 Trident is available for licensing as of 29 Nov 2021. https://www.inventprise.com/?page_id=1938
  • 29 Nov 2021 Inventprise has patent protection for technologies associated with viral vaccines as of November 2021 (Inventprise website, November 2021)
  • 29 Nov 2021 Early research in COVID-2019 infections (Prevention) in USA (Parenteral) as of November 2021 (Inventprise pipeline, November 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top